New pill could slow MS disability in major trial
NCT ID NCT07299019
First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 17 times
Summary
This Phase 3 trial tests an oral drug called orelabrutinib against a placebo in about 990 people with non-active secondary progressive multiple sclerosis (MS). The goal is to see if the drug can delay worsening disability over 24 to 60 months. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor their doctors will know which they are getting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Orelabrutinib (a drug taken orally that targets a protein called BTK to potentially slow disability progression)
- What this could lead to
- If it works, this could provide a new treatment option to slow disability progression in people with non-active secondary progressive multiple sclerosis.
- What could go wrong
- This is a large Phase 3 trial, but it is still experimental. The drug may not prove effective in slowing disability, and side effects are possible. Results will take years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Aqualane Clinical Research
RECRUITINGNaples, Florida, 34105, United States
-
Arizona Neuroscience Research, LLC
RECRUITINGPhoenix, Arizona, 85032, United States
-
Boston Clinical Trials
WITHDRAWNBoston, Massachusetts, 02131, United States
-
EUROMEDIS Osrodek Badan Klinicznych
RECRUITINGSzczecin, 70-111, Poland
-
Fullerton Neurology and Headache Center
RECRUITINGFullerton, California, 92835, United States
-
Galen Clinic
RECRUITINGLublin, 20-064, Poland
-
Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed))
RECRUITINGTorrance, California, 90502-2006, United States
-
Hospital of Lithuanian University of Health Sciences
RECRUITINGKaunas, Kauno, 50161, Lithuania
-
Josephson Wallack Munshower Neurology, Pc Suite 225
RECRUITINGIndianapolis, Indiana, 46256, United States
-
KC Research Center, PA Neurology Research Dept
RECRUITINGRoeland Park, Kansas, 66205, United States
-
Lone Star Neurology
RECRUITINGSan Antonio, Texas, 78258, United States
-
MA-LEK Clinical Sp. z o.o.
RECRUITINGKatowice, 40-571, Poland
-
MS and Neuromuscular Center of Excellence
RECRUITINGClearwater, Florida, 33761, United States
-
Malva Trials
RECRUITINGLublin, 20-601, Poland
-
NEUROHK, s.r.o.
RECRUITINGChoceň, 56501, Czechia
-
NZOZ Novo Med
RECRUITINGKatowice, Silesian Voivodeship, 40-584, Poland
-
Neurology Associates
RECRUITINGMaitland, Florida, 32751, United States
-
Nmedis sp. z o.o.
RECRUITINGRzeszów, Rzeszów, 35-323, Poland
-
Nova Clinical Research, LLC
RECRUITINGBradenton, Florida, 34209, United States
-
OMRF Multiple Sclerosis Center of Excellence
RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
Perseverance Research Center, LLC (PRC)
RECRUITINGScottsdale, Arizona, 85253, United States
-
Premier Neurology
RECRUITINGGreenville, South Carolina, 29605, United States
-
Profound Research LLC at Oakland Neurology Center
RECRUITINGRochester Hills, Michigan, 48307, United States
-
Regina Berkovich MD, PhD Inc
RECRUITINGWest Hollywood, California, 90048, United States
-
SFM Clinical Research, LLC
RECRUITINGBoca Raton, Florida, 33487, United States
-
Texas Institute for Neurological Disorders - Sherman
RECRUITINGSherman, Texas, 75092, United States
-
The Boster Center for Multiple Sclerosis
RECRUITINGColumbus, Ohio, 43235, United States
-
Twoja Przychodnia Centrum Medyczne Nowa Sól
RECRUITINGNowa Sól, Lubusz Voivodeship, 67-100, Poland
-
University Clinical Centre of Kragujevac
RECRUITINGKragujevac, 3400, Serbia
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood pressure pill slow MS disability?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Could a common supplement fight fatigue in progressive MS?
- Nurse-Led video calls aim to empower MS patients
- Cheaper MS drug could match pricey standard in major trial
- Experimental cell therapy takes on multiple sclerosis